Ruth Ferreri, APRN
Acute Care · New Haven, CTNPI 1629268156
Payments from drug & device makers
Across 13 payments — averaging $27.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$65
- EMD Serono, Inc.$60
- Mallinckrodt Hospital Products Inc.$34
- Vanda Pharmaceuticals Inc.$29
- UCB, Inc.$29
- Siemens Medical Solutions USA, Inc.$29
- plus $108 from 5 others
What the payments were for
- Food & beverage$354100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 1 | $65 |
| EMD Serono, Inc. | 2 | $60 |
| Mallinckrodt Hospital Products Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| UCB, Inc. | 1 | $29 |
| Siemens Medical Solutions USA, Inc. | 1 | $29 |
| Progenics Pharmaceuticals, Inc. | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| AbbVie | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Merz Pharmaceuticals, LLC | 1 | $14 |
How this compares
$354 in reported general payments places this provider in the 65th percentile of 239 acute care providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 21 | $988 |
| Dexamethasone | 32 | $510 |
| Tamsulosin Hcl | 40 | $426 |
| Lidocaine Hcl ViscousLidocaine Hcl | 15 | $378 |
| Doxepin Hcl | 15 | $377 |
| Levetiracetam | 14 | $340 |
| Oxycodone Hcl | 15 | $243 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $205 |
| Methylprednisolone | 13 | $129 |
| Diazepam | 23 | $30 |
Paid to pharmacies, not to this prescriber.
Other acute care in New Haven
- Mona ShahbaziNew Haven$30K
- Angela ScottNew Haven$1K
- Hassen BorhotManchester$75K
- Terea GuimaraesBranford$36K
- Rosanna MenditeHartford$11K
- Nicola CalabreseMiddletown$9K
- Mary CicchettiHartford$7K
- Daniel MeewesHartford$7K
- Tara HalpinWethersfield$6K
- Wayne RockhillWaterbury$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.